The Board of Amasse Capital Holdings Limited announced that on 30 May 2023 (after trading hours), the Company and Guangming Great Health entered into the MOU whereby the Parties agreed to negotiate in good faith to enter into the Formal Agreement on the Possible Cooperation (as defined below). A summary of the major terms of the MOU is set out below: Parties: (i) the Company; and (ii) Guangming Great Health. To the best of the Directors' knowledge, information and belief, having made all reasonable enquiries, Guangming Great Health and its ultimate beneficial owner(s) are third parties independent of and not connected with the Company and its connected persons.

Subject matter: Subject to further negotiations and the terms and conditions to be set out in the Formal Agreement, the Parties agreed to negotiate for cooperation on Chinese materia medica business of Guangming Great Health, the cooperation methods include, but not limited to, acquisition of equity interest of Guangming Great Health, establishment of joint venture, establishment of limited partnership and/or provision of financing (the "Possible Cooperation"). Formal Agreement: Pursuant to the MOU, the Company will negotiate and procure to enter into the Formal Agreement within three months (or such other date may agree by the Parties) from the date of the MOU. Termination: If the Parties are unable to enter into the Formal Agreement within three months (or such other date may agree by the Parties) from the date of the MOU, the MOU shall be terminated.